Immune Biologics Pty Ltd cancelled the acquisition of IMM-124E from Immuron Limited.
Immune Biologics Pty Ltd cancelled the acquisition of IMM-124E from Immuron Limited (ASX:IMC) on January 6, 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 AUD | +2.04% | +20.48% | +29.87% |
15/07 | Immuron Limited Reports Unaudited Sales Results for the Fiscal Fourth Quarter and Full Year Ended June 2024 | CI |
15/07 | Immuron Posts 253% Jump in Travelan Sales in Fiscal Q4; Shares Rise 10% | MT |
1st Jan change | Capi. | |
---|---|---|
+29.87% | 15.14M | |
+7.40% | 101B | |
+7.76% | 42.18B | |
-14.37% | 32.26B | |
+81.56% | 29.79B | |
-12.27% | 16.06B | |
+2.33% | 14.45B | |
-8.56% | 12.01B | |
+182.74% | 10.71B | |
+2.17% | 8.89B |